Anne Kever

PhD

Scientist, Keenan Research Centre for Biomedical Science

Biography

Anne Kever is a research scientist at the Keenan Research Centre for Biomedical Science (KRCBS) and the Barlo Multiple Sclerosis Centre. She obtained her Master and PhD in cognitive psychology from the Université catholique de Louvain in Belgium. She is also a trained clinical psychologist specialized in cognitive-behavioral therapy. During a 3-year postdoc at the Columbia University Irving Medical Center, she acquired extensive knowledge in the field of Multiple Sclerosis (MS). Her primary research focus lies in understanding implications of psychosocial and cognitive factors for physical and mental health in clinical populations, particularly persons MS. She also recently developed a research program examining the role of cognitive biases in chronic, MS-related pain. Her goal is to use empirical methods to design targeted, evidence-based treatments to reduce disease-burden and improve quality of life in patients dealing with chronic (neurological) conditions. Despite her short career, she has published over 15 papers as first-author in international, peer-reviewed journals and regularly acts as reviewer for different scientific journals.

Recent Publications

  1. Kever, A, Feinstein, A. Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use. Mult Scler Relat Disord. 2025;105 :106874. doi: 10.1016/j.msard.2025.106874. PubMed PMID:41313862 .
  2. Feinstein, A, Bar-Or, A, Benedict, RHB, Filippi, M, Freedman, DE, Kever, A et al.. Is multiple sclerosis-related depression different from depression in general? The data for and against. Brain. 2025;148 (12):4210-4221. doi: 10.1093/brain/awaf319. PubMed PMID:41251688 .
  3. Demchenko, I, Tailor, I, Chegini, S, Yu, H, Gholamali Nezhad, F, Rueda, A et al.. Human applications of transcranial temporal interference stimulation: A systematic review. Brain Stimul. 2025;18 (6):2054-2066. doi: 10.1016/j.brs.2025.10.023. PubMed PMID:41167554 .
  4. Kever, A, Kang, N, Meza, C, Pogacar, M, Lui, R, Hennessy, K et al.. Not for everyone: examining predictors of cognitive rehabilitation success in multiple sclerosis. J Neurol. 2025;272 (9):593. doi: 10.1007/s00415-025-13345-0. PubMed PMID:40858802 .
  5. Demchenko, I, Tailor, I, Chegini, S, Yu, H, Nezhad, FG, Rueda, A et al.. WITHDRAWN: Human Applications of Transcranial Temporal Interference Stimulation: A Systematic Review. Brain Stimul. 2025; :. doi: 10.1016/j.brs.2025.08.010. PubMed PMID:40835066 .
  6. Kever, A, Meza, C, Feinstein, A. Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample. Eur J Neurol. 2025;32 (7):e70142. doi: 10.1111/ene.70142. PubMed PMID:40616362 PubMed Central PMC12228000.
  7. Demchenko, I, Tailor, I, Chegini, S, Yu, H, Gholamali Nezhad, F, Rueda, A et al.. Human Applications of Transcranial Temporal Interference Stimulation: A Systematic Review. medRxiv. 2025; :. doi: 10.1101/2025.05.16.25327804. PubMed PMID:40463528 PubMed Central PMC12132165.
  8. Kever, A, Heuer, LB, Simani, L, Leavitt, VM. Development and initial validation of the Cognitive Change Scale (CCS). Mult Scler. 2024;30 (14):1815-1824. doi: 10.1177/13524585241290102. PubMed PMID:39511937 .
  9. Kever, A, Aguerre, IM, Vargas, W, Straus Farber, R, Levine, L, Riley, CS et al.. Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosis. Clin Rehabil. 2022;36 (10):1305-1313. doi: 10.1177/02692155221107077. PubMed PMID:35673256 .
  10. Kever, A, Walker, ELS, Riley, CS, Heyman, RA, Xia, Z, Leavitt, VM et al.. Association of personality traits with physical function, cognition, and mood in multiple sclerosis. Mult Scler Relat Disord. 2022;59 :103648. doi: 10.1016/j.msard.2022.103648. PubMed PMID:35134623 PubMed Central PMC8986589.
Search PubMed